Clinical Trial Update: Selinexor in Combination With Immunomodulator （Thalidomide/Pomalidomide/Lenalidomide）in RRMM [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating selinexor in combination with an immunomodulator (thalidomide/pomalidomide/lenalidomide) for relapsed/refractory multiple my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Immunomodulator (thalidomide/pomalidomide/lenalidomide)
• Selinexor (selinexor)

Snippet

Sponsor: Juan Du | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN